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Correction to: Vaccination with nanoparticles
combined with micro-adjuvants protects
against cancer
Mona O. Mohsen1,2,11*, Matthew D. Heath3, Gustavo Cabral-Miranda2, Cyrill Lipp2, Andris Zeltins4, Marcos Sande5,
Jens V. Stein6, Carsten Riether7, Elisa Roesti2, Lisha Zha2,8, Paul Engeroff2, Aadil El-Turabi1, Thomas M. Kundig9,
Monique Vogel2, Murray A. Skinner3, Daniel E. Speiser10, Alexander Knuth11, Matthias F. Kramer3 and
Martin F. Bachmann1,2
Correction to: J ImmunoTherapy Cancer
https://doi.org/10.1186/s40425-019-0587-z
Following publication of the original article [1], the
authors reported an author’s family name has been
erroneously spelled. Paul Engroff should be replaced
Paul Engeroff.
Furthermore, there are two errors in the following af-
filiations: 9) Department of dermatology, University of
Zurich, Bern, Switzerland and 10) Department of Oncol-
ogy, University of Lausanne, Bern,Switzerland should be
replaced with 9) Department of dermatology, University
of Zurich, Zurich, Switzerland and 10) Department of
Oncology, University of Lausanne, Lausanne,
Switzerland.
The corrections have been implemented in the original
article as well.
The publisher apologized for any inconvenience this
might has caused.
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